EPISODE · Sep 22, 2016 · 22 MIN
Biotech: The good times aren't over
from Investors' Chronicle
Lower valuations make now a good buying opportunity for long-term growth in the biotech sectorInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
Biotech: The good times aren't over
0:00
22:11
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Investors' Chronicle?
This episode is 22 minutes long.
When was this Investors' Chronicle episode published?
This episode was published on September 22, 2016.
Can I download this Investors' Chronicle episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!